Phase II trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and intensity moduled radiation therapy (IMRT) for locally advanced head and neck cancer

被引：0
|
作者：
Kao, J. [1 ]
Policarpio, L. [1 ]
Teng, M. [1 ]
Burri, R. [1 ]
Genden, E. [1 ]
Packer, S. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6014
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer
    Vokes, EE
    Haraf, DJ
    Brockstein, BE
    Weichselbaum, RR
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (02) : 70 - 76
  • [22] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATIN (FAP) FOLLOWED BY RADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER
    WAGENER, DJT
    VANHOESEL, QGCM
    YAP, SH
    HOOGENRAAD, WJ
    WOBBES, T
    STRIJK, SP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (02) : 131 - 134
  • [23] Concurrent Cetuximab and Radiation Therapy in Patients with Locoregionally Advanced Head and Neck Cancer
    Cheng, H. C.
    Ngan, R. K. C.
    Au, K. H.
    HONG KONG JOURNAL OF RADIOLOGY, 2012, 15 (01): : 29 - 35
  • [24] A phase I/II study of radiation therapy, paclitaxel poliglumex, and cetuximab in locally advanced head and neck cancer.
    Hahn, Seung Shin
    Bogart, Jeffrey
    Chung, Taik Chung
    Hsu, Jack
    Kellman, Robert
    Kim, Jung-Ah
    Graziano, Steve
    Martin, Dena
    Gajra, Ajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
    Chun, Stephen G.
    Hughes, Randall
    Sumer, Baran D.
    Myers, Larry L.
    Truelson, John M.
    Khan, Saad A.
    Ma, Tsung-Wei
    Xie, Yang
    Yordy, John S.
    Cooley, Susan
    Wu, Jean
    Choy, Hak
    Nedzi, Lucien A.
    CANCER INVESTIGATION, 2017, 35 (01) : 23 - 31
  • [26] Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck canceraEuro
    Argiris, A.
    Bauman, J. E.
    Ohr, J.
    Gooding, W. E.
    Heron, D. E.
    Duvvuri, U.
    Kubicek, G. J.
    Posluszny, D. M.
    Vassilakopoulou, M.
    Kim, S.
    Grandis, J. R.
    Johnson, J. T.
    Gibson, M. K.
    Clump, D. A.
    Flaherty, J. T.
    Chiosea, S. I.
    Branstetter, B.
    Ferris, R. L.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1594 - 1600
  • [27] Nimotuzumab and Intensity Modulated Radiation Therapy (IMRT) in the Concurrent Setting of Locally Advanced Head and Neck Cancers: Early Results of a Prospective Trial in India
    Talapatra, K.
    Deshpande, M.
    Goyle, S.
    Majumder, D.
    Badhwar, S.
    Mistry, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E359 - E359
  • [28] Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
    Blaszkowsky, L. S.
    Ryan, D. P.
    Szymonifka, J.
    Borger, D. R.
    Zhu, A. X.
    Clark, J. W.
    Kwak, E. L.
    Mamon, H. J.
    Allen, J. N.
    Vasudev, E.
    Shellito, P. C.
    Cusack, J. C.
    Berger, D. L.
    Hong, T. S.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 121 - 126
  • [29] Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab
    Koutcher, Lawrence D.
    Wolden, Suzanne
    Lee, Nancy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 472 - 476
  • [30] CONCOMITANT HYDROXYUREA, 5-FLUOROURACIL, AND RADIATION-THERAPY FOR RECURRENT HEAD AND NECK-CANCER - EARLY RESULTS
    VOKES, EE
    PANJE, WR
    WEICHSELBAUM, RR
    SCHILSKY, RL
    MORAN, WJ
    AWAN, AM
    GUARNIERI, CM
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1988, 98 (04) : 295 - 298
12345